Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
2(15%)
Results Posted
20%(2 trials)

Phase Distribution

Ph phase_2
1
8%
Ph not_applicable
6
46%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
1(14.3%)
N/ANon-phased studies
6(85.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

10 of 10 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

13

all time

Status Distribution
Active(2)
Completed(10)
Other(1)

Detailed Status

Completed10
Recruiting2
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
2
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (14.3%)
N/A6 (85.7%)

Trials by Status

completed1077%
recruiting215%
suspended18%

Recent Activity

Clinical Trials (13)

Showing 13 of 13 trials

All 13 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
13